The PE Ratio as of December 2024 (TTM) for Seagen Inc. (SGEN) is -57.19

According to Seagen Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -57.19. This represents a change of 24.73% compared to the average of -45.85 of the last 4 quarters.

Seagen Inc. (SGEN) Historical PE Ratio (quarterly & annually)

How has SGEN PE Ratio performed in the past?

The mean historical PE Ratio of Seagen Inc. over the last ten years is -66.12. The current -57.19 PE Ratio has changed 8.55% with respect to the historical average. Over the past ten years (40 quarters), SGEN's PE Ratio was at its highest in in the December 2019 quarter at 189.81. The PE Ratio was at its lowest in in the June 2020 quarter at -347.63.

Seagen Inc. (SGEN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Seagen Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Seagen Inc. (SGEN) Average PE Ratio

How has SGEN PE Ratio performed in the past?

The current PE Ratio of Seagen Inc. (SGEN) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Seagen Inc. (SGEN) PE Ratio vs. Peers

How is SGEN’s PE Ratio compared to its peers?

Seagen Inc.’s PE Ratio is less than BioMarin Pharmaceutical Inc. (39.37), greater than Alnylam Pharmaceuticals, Inc. (-94.14), less than Exelixis, Inc. (20.69), less than Halozyme Therapeutics, Inc. (15.37), less than Legend Biotech Corporation (-17.16), less than Zai Lab Limited (-0.97), less than Ascendis Pharma A/S (-17.83), less than Incyte Corporation (414.59), less than United Therapeutics Corporation (14.49), less than Ultragenyx Pharmaceutical Inc. (-7.47), less than Apellis Pharmaceuticals, Inc. (-16.51), less than Viking Therapeutics, Inc. (-47.37), greater than TG Therapeutics, Inc. (-324.87), less than X4 Pharmaceuticals, Inc. (-6.95), less than PDS Biotechnology Corporation (-1.49), less than Madrigal Pharmaceuticals, Inc. (-13.08), less than IVERIC bio, Inc. (-27.51), less than Immunovant, Inc. (-11.83), less than Akero Therapeutics, Inc. (-8.36),

Build a custom stock screener for Seagen Inc. (SGEN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Seagen Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Seagen Inc. (SGEN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Seagen Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.